Using native and inactivated leukotoxin Mannheimia haemolytica in specific immunoprophylaxis of sheep's respiratory syndrome
Języki publikacji
PL
Abstrakty
EN
The purpose of this study was to compare the immunostimulating properties and prophylactic effects of native M. haemolytica leukotoxin (Lkt) which was inactivated by formaldehyde and glutaraldehyde. The study also estimated the neutralizing properties of antibodies induced by different forms of Lkt and their protective effects on experimental challenge in sheep. The results of the study suggest that the inactivation procedure has an important effect on immunogenic obtained toxins. Vaccines used in the immunized animals demonstrated an immunogenic presence which was observed in an increase of the specific antibody titers in sera following immunization. An increase in the neutralizing properties of antibodies contained in the sera of animals immunized by Lkt was also observed. The obtained results indicate the possibility of a more effective use of M. haemolytica Lkt isolated from bovine respiratory syndrome as a subunit of the vaccines already used in immunoprophylaxis of this disease in sheep.
1.Blanchard-Channell M. T., Ashfaq M. K., Kadel W. L.: Efficacy of a streptomycin dependent, live Pasteurella haemolytica vaccine against challenge exposure to Pasteurella haemolytica in cattle. Am. J. Vet. Res. 1987, 48, 637-642.
2.Bowersock T. L., Waleed W. S., Shalaby L. M., Levy M., Samules M. L., Lallone R., White M. R., Borie D. L., Lehmeyer J., Park K.: Evaluation of an administered vaccine using hydrogels containing bacterial exotoxins of Pasteurella haemolytica, in cattle. Am. J. Vet. Res. 1994, 55, 500-509.
3.Burrows L. L., Olah-Winfield E., Lo R. Y. C.: Molecular analysis of the leukotoxin determinants from P. haemolytica serotypes 1 to 16. Infect. Immun. 1993, 61, 5001-5007.
4.Clinkenbeard K. D., Upton M. L.: Lysis of bovine platelets by Pasteurella haemolytica leukotoxin. Am. J. Vet. Res. 1991, 52, 453-457.
5.Clinkenbeard K. D., Clinkenbeard C. R., Waurzyniak B. J.: Chaotropic agents cause disaggregation and enhanced activity of P. haemolytica leukotoxin. Vet. Microbiol. 1995, 45, 201-209.
6.Confer A. W., Clikenbeard K. D., Gatewood D. M., Driskel B. A., Montelongo M.: Serum antibody responses of cattle vaccinated with partially purified native P. haemolytica leukotoxin. Vaccine 1997, 15, 1423-1429.
7.Conlon J. A., Shewen P. E., Lo R. Y. C.: Efficacy of recombinant leukotoxin in protection against pneumonic challenge with live Pasteurella haemolytica A1. Infect. Immunol. 1991, 59, 587-591.
8.Davies R. L., Whittam T. S., Selander R. K.: Sequence diversity and molecular evolution of the leukotoxin (lktA) gene in bovine and ovine strains of Mannheimia (Pasteurella) haemolytica. J. Bacteriol. 2001, 183, 1394-1404.
9.Fodor L., Varga J., Hajtos I., Molnar T.: Serotypes of Pasteurella haemolytica and Pasteurella trehalosi isolated from farm animal in Hungary. Zentralbl. Veterinarmed. B 1999, 46, 241-247.
10.Le Buanec H., Bizzini B.: Procedures for preparing biologically inactive, but immunogenic HIV-1 Tat protein (Tat Toxoid) for human use. Biomed. Pharmacother. 2000, 54, 41-44.
11.Purdy C. W., Straus D. C.: Efficacy of a capsule preparation and ultravioletkilled Pasteurella haemolytica A1 vaccine in goats. Small Rumin. Res. 1995, 15, 177-186.
12.Ramirez-Romero R., Brodgen K. A., Gallup J. M., Sonea I. M., Ackermann M. R.: Mast cell density and substance P-like immunoreactivity during the initiation and progression of lung lesions in ovine Mannheimia (Pasteurella) haemolytica pneumonia. Microb. Pathog. 2001, 30, 325-335.
13.Srinand S., Ames T. R., Maheswaran S. K., King V. L.: Efficacy of various vaccines against pneumonic pasteurellosis in cattle: a meta-analysis. Prev. Vet. Med. 1995, 25, 7-17.
14.Vega M. V., Maheswaran S. K., Leininger J. R., Ames T. R.: Adaptation of colorimetric microtitration assay for quantifying Pasteurella haemolytica A1 leukotoxin and antileukotoxin. Am. J. Vet. Res. 1987, 48, 1559-1564.
15.Wernicki A., Puchalski A., Urban-Chmiel R.: Antybiotykowrażliwość oraz profil plazmidowy szczepów Pasteurella haemolytica. Medycyna Wet. 1999, 55, 623-626.